COO vs. BLCO, ALC, TEVA, ALGN, ALNY, GMAB, MOH, WAT, BAX, and HOLX
Should you be buying Cooper Companies stock or one of its competitors? The main competitors of Cooper Companies include Bausch + Lomb (BLCO), Alcon (ALC), Teva Pharmaceutical Industries (TEVA), Align Technology (ALGN), Alnylam Pharmaceuticals (ALNY), Genmab A/S (GMAB), Molina Healthcare (MOH), Waters (WAT), Baxter International (BAX), and Hologic (HOLX). These companies are all part of the "medical" sector.
Cooper Companies (NASDAQ:COO) and Bausch + Lomb (NYSE:BLCO) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, community ranking, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.
Cooper Companies received 584 more outperform votes than Bausch + Lomb when rated by MarketBeat users. Likewise, 66.59% of users gave Cooper Companies an outperform vote while only 38.71% of users gave Bausch + Lomb an outperform vote.
24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are owned by institutional investors. 2.0% of Cooper Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Cooper Companies has a net margin of 7.93% compared to Bausch + Lomb's net margin of -7.81%. Cooper Companies' return on equity of 8.79% beat Bausch + Lomb's return on equity.
Cooper Companies has higher earnings, but lower revenue than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.
Cooper Companies presently has a consensus target price of $109.69, suggesting a potential upside of 19.65%. Bausch + Lomb has a consensus target price of $19.45, suggesting a potential upside of 26.82%. Given Bausch + Lomb's higher probable upside, analysts clearly believe Bausch + Lomb is more favorable than Cooper Companies.
Cooper Companies has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, Bausch + Lomb has a beta of 0.47, suggesting that its share price is 53% less volatile than the S&P 500.
In the previous week, Cooper Companies had 10 more articles in the media than Bausch + Lomb. MarketBeat recorded 18 mentions for Cooper Companies and 8 mentions for Bausch + Lomb. Cooper Companies' average media sentiment score of 0.47 beat Bausch + Lomb's score of 0.44 indicating that Cooper Companies is being referred to more favorably in the media.
Summary
Cooper Companies beats Bausch + Lomb on 16 of the 18 factors compared between the two stocks.
Get Cooper Companies News Delivered to You Automatically
Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cooper Companies Competitors List
Related Companies and Tools
